Evaluation and management of fungal infections in immunocompromised patients.
Publication
, Journal Article
Venkatesan, P; Perfect, JR; Myers, SA
Published in: Dermatol Ther
2005
As the population of chronically immunosuppressed individuals continues to grow, the prevalence of fungal infections is increasing. Fungal infections in this patient population represent challenges in diagnosis and management. This article will review the common superficial and invasive mycoses that occur in the solid organ transplant and HIV-infected populations. Disease presentations are reviewed, but emphasis is placed on cutaneous manifestations. Recent advances in antifungal therapy and their direct application to specific diseases provide important new approaches to this complex and often seriously ill patient population.
Duke Scholars
Published In
Dermatol Ther
DOI
ISSN
1396-0296
Publication Date
2005
Volume
18
Issue
1
Start / End Page
44 / 57
Location
United States
Related Subject Headings
- Organ Transplantation
- Mycoses
- Immunosuppressive Agents
- Immunocompromised Host
- Humans
- HIV Infections
- Dermatomycoses
- Dermatology & Venereal Diseases
- Chemoprevention
- Antifungal Agents
Citation
APA
Chicago
ICMJE
MLA
NLM
Venkatesan, P., Perfect, J. R., & Myers, S. A. (2005). Evaluation and management of fungal infections in immunocompromised patients. Dermatol Ther, 18(1), 44–57. https://doi.org/10.1111/j.1529-8019.2005.05001.x
Venkatesan, Priya, John R. Perfect, and Sarah A. Myers. “Evaluation and management of fungal infections in immunocompromised patients.” Dermatol Ther 18, no. 1 (2005): 44–57. https://doi.org/10.1111/j.1529-8019.2005.05001.x.
Venkatesan P, Perfect JR, Myers SA. Evaluation and management of fungal infections in immunocompromised patients. Dermatol Ther. 2005;18(1):44–57.
Venkatesan, Priya, et al. “Evaluation and management of fungal infections in immunocompromised patients.” Dermatol Ther, vol. 18, no. 1, 2005, pp. 44–57. Pubmed, doi:10.1111/j.1529-8019.2005.05001.x.
Venkatesan P, Perfect JR, Myers SA. Evaluation and management of fungal infections in immunocompromised patients. Dermatol Ther. 2005;18(1):44–57.
Published In
Dermatol Ther
DOI
ISSN
1396-0296
Publication Date
2005
Volume
18
Issue
1
Start / End Page
44 / 57
Location
United States
Related Subject Headings
- Organ Transplantation
- Mycoses
- Immunosuppressive Agents
- Immunocompromised Host
- Humans
- HIV Infections
- Dermatomycoses
- Dermatology & Venereal Diseases
- Chemoprevention
- Antifungal Agents